Chang Che-Chia, Chen Tzu-Ping, Yeh Chi-Hsiao, Huang Pin-Fu, Wang Yao-Chang, Yin Shun-Ying
Division of Thoracic and Cardiovascular Surgery, Chang Gung Memorial Hospital, Keelung, Taiwan;; Division of Thoracic and Cardiovascular Surgery, Chang Gung Memorial Hospital, Linkou, Taiwan.
Division of Thoracic and Cardiovascular Surgery, Chang Gung Memorial Hospital, Keelung, Taiwan.
J Thorac Dis. 2016 Nov;8(11):3168-3174. doi: 10.21037/jtd.2016.11.93.
The selection of ideal candidates for surgical intervention among patients with parapneumonic pleural effusion remains challenging. In this retrospective study, we sought to identify the main predictors of surgical treatment and devise a simple scoring system to guide surgical decision-making.
Between 2005 and 2014, we identified 276 patients with parapneumonic pleural effusion. Patients in the training set (n=201) were divided into two groups according to their treatment modality (non-surgery surgery). Using multivariable logistic regression analysis, we devised a scoring system to guide surgical decision-making. The score was subsequently validated in an independent set of 75 patients.
A white blood cell count >13,500/µL, pleuritic pain, loculations, and split pleura sign were identified as independent predictors of surgical treatment. A weighted score based on these factors was devised, as follows: white blood cell count >13,500/µL (one point), pleuritic pain (one point), loculations (two points), and split pleura sign (three points). A score >4 was associated with a surgical approach with a sensitivity of 93.4%, a specificity of 82.4%, and an area under curve (AUC) of 0.879 (95% confidence interval: 0.828-0.930). In the validation set, a sensitivity of 94.3% and a specificity of 79.6% were found (AUC=0.869).
The proposed scoring system reliably identifies patients with parapneumonic pleural effusion who are candidates for surgery. Pending independent external validation, our score may inform the appropriate use of surgical interventions in this clinical setting.
在肺炎旁胸腔积液患者中选择理想的手术干预候选人仍然具有挑战性。在这项回顾性研究中,我们试图确定手术治疗的主要预测因素,并设计一个简单的评分系统来指导手术决策。
2005年至2014年期间,我们确定了276例肺炎旁胸腔积液患者。训练集(n = 201)中的患者根据其治疗方式(非手术/手术)分为两组。使用多变量逻辑回归分析,我们设计了一个评分系统来指导手术决策。随后在一组独立的75例患者中对该评分进行了验证。
白细胞计数>13,500/µL、胸膜炎性疼痛、分隔和胸膜分裂征被确定为手术治疗的独立预测因素。基于这些因素设计了一个加权评分,如下:白细胞计数>13,500/µL(1分)、胸膜炎性疼痛(1分)、分隔(2分)和胸膜分裂征(3分)。评分>4与手术治疗相关,敏感性为93.4%,特异性为82.4%,曲线下面积(AUC)为0.879(95%置信区间:0.828 - 0.930)。在验证组中,敏感性为94.3%,特异性为79.6%(AUC = 0.869)。
所提出的评分系统能够可靠地识别肺炎旁胸腔积液中适合手术的患者。在进行独立的外部验证之前,我们的评分可能有助于在这种临床情况下合理使用手术干预。